Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
about
Reduction of breast density following tamoxifen treatment evaluated by 3-D MRI: preliminary studyIncidence of chemotherapy-induced amenorrhea associated with epirubicin, docetaxel and navelbine in younger breast cancer patients.Presentation and management of docetaxel-related adverse effects in patients with breast cancerDecrease in breast density in the contralateral normal breast of patients receiving neoadjuvant chemotherapy: MR imaging evaluationChanges in ovarian function in premenopausal women with breast cancer undergoing adjuvant TC (docetaxel and cyclophosphamide) chemotherapy during a brief period of amenorrhea around the last chemotherapy cycle.Longer therapy, iatrogenic amenorrhea, and survival in early breast cancer.The risk of amenorrhea is related to chemotherapy-induced leucopenia in breast cancer patients receiving epirubicin and taxane based chemotherapy.Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809.Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial.The psychosocial impact of interrupted childbearing in long-term female cancer survivors.Biomarker prediction of chemotherapy-related amenorrhea in premenopausal women with breast cancer participating in E5103.Fertility preservation and breast cancer: a reviewChemotherapy-Related Amenorrhea and Menopause in Young Chinese Breast Cancer Patients: Analysis on Incidence, Risk Factors and Serum Hormone ProfilesThe Globalization of Cooperative Groups.Chemotherapy-Induced Amenorrhea - An UpdateElevated risks of subsequent endometrial cancer development among breast cancer survivors with different hormone receptor status: a SEER analysis.The advantage of letrozole over tamoxifen in the BIG 1-98 trial is consistent in younger postmenopausal women and in those with chemotherapy-induced menopause.Impact of chemotherapy-induced amenorrhea in breast cancer patients: the evaluation of ovarian function by menstrual history and hormonal levelsDietary pattern influences breast cancer prognosis in women without hot flashes: the women's healthy eating and living trialPrognostic Effects of Adjuvant Chemotherapy-Induced Amenorrhea and Subsequent Resumption of Menstruation for Premenopausal Breast Cancer Patients.Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation.Chemotherapy-induced amenorrhea: a prospective study of brain activation changes and neurocognitive correlates.Breast cancer and fertility preservationThe correlation of age with chemotherapy-induced ovarian function failure in breast cancer patients.Fertility and reproductive considerations in premenopausal patients with breast cancer.Medical approaches to preservation of fertility in female cancer patients.Prevention of ovarian damage and infertility in young female cancer patients awaiting chemotherapy--clinical approach and unsolved issues.Association of tamoxifen use and ovarian function in patients with invasive or pre-invasive breast cancer.
P2860
Q24625216-40B461F7-B068-4ACA-9582-7E4963F6696EQ33601886-BDD9F690-E0DD-4BA8-8E07-357C1E6E78F9Q33698286-088691CC-4670-490A-83B7-8B284FC9249FQ33746620-E6B667A5-349A-4B8B-8599-1BEE99B86083Q33955356-9BF4C9B8-45EE-472E-A15C-62137AE68D58Q34109991-5758F3DD-807B-4D67-8A2F-E93580803690Q34277890-11F01ACB-4ABC-4D0D-946B-48F48CFB6E5DQ34414177-6ADA7EE9-F83B-488F-8BCB-EA626244E252Q34877439-22694736-FB4E-44F9-A790-2F53F1BF5691Q35069536-CD4F394D-B58F-4C48-96E5-724E18FCF61DQ35100279-A80D7DC3-E861-4853-869F-7BE4ECB375EEQ35106163-5FA129E7-A1F0-4777-B4BA-15AD9BC340C8Q35814842-B7B1B2AB-C878-4246-B2A6-365D92D68100Q36119749-4B23C36F-E0AA-476B-937F-58EDC79886F1Q36295133-296E962C-BC0C-4257-9246-E0161A9A57CCQ36416307-7671EB14-D0E7-42B3-9426-90D6670B2B64Q36713321-3AF79DF3-30F0-4EC2-96BE-235A86C52032Q36885123-E284C213-EB7D-432B-B27C-6EDA0C2B8CDBQ37104757-B2C49816-3339-49E6-8150-6C02783E67CFQ37206820-DD37A33F-83C0-4CDF-B78E-30C988CC807AQ37249356-DF42A924-0134-4FDA-9A0A-1E3FB6A5FD21Q37284872-8C0A70EC-AFE2-4668-8907-0768D1BD3D36Q37612074-8F30415C-F8CC-42D9-AD3D-74C649FBAF18Q37706917-DEC6D72C-9CF9-4D68-8B55-86D801516E9DQ37776142-B1D00EA8-31D8-4F73-AC05-F600F45DE9F0Q37831349-BF91EB28-387D-4558-9A22-C05BC9FF6822Q37938748-CAE5DE89-4205-48FE-AB23-06A300FD91F7Q38981509-F6ECAA1B-3658-4BD3-A78B-B2FCA1511B1D
P2860
Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Amenorrhea in premenopausal wo ...... taxel arm of NSABP B-30 trial.
@en
Amenorrhea in premenopausal wo ...... taxel arm of NSABP B-30 trial.
@nl
type
label
Amenorrhea in premenopausal wo ...... taxel arm of NSABP B-30 trial.
@en
Amenorrhea in premenopausal wo ...... taxel arm of NSABP B-30 trial.
@nl
prefLabel
Amenorrhea in premenopausal wo ...... taxel arm of NSABP B-30 trial.
@en
Amenorrhea in premenopausal wo ...... taxel arm of NSABP B-30 trial.
@nl
P2093
P2860
P1476
Amenorrhea in premenopausal wo ...... etaxel arm of NSABP B-30 trial
@en
P2093
Eleftherios P Mamounas
Joseph P Costantino
Marcie W Ritter
Norman Wolmark
Patricia A Ganz
Stephanie R Land
P2860
P2888
P304
P356
10.1007/S10549-008-9937-0
P407
P577
2008-02-27T00:00:00Z